Sanofi Consumer Healthcare Inc Stock Price Today (NSE: SANOFICONR)
Fundamental Score
Sanofi Consumer Healthcare Inc Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Sanofi Consumer Healthcare Inc share price today is ₹4085.50, up +0.00% on NSE/BSE as of 17 April 2026. Sanofi Consumer Healthcare Inc (SANOFICONR) is a Mid-cap company in the Pharmaceuticals sector with a market capitalisation of ₹10.65K (Cr). The 52-week high for SANOFICONR share price is ₹5894.50 and the 52-week low is ₹3975.00. At a P/E ratio of 49.57x, SANOFICONR is currently trading above its industry average P/E of 31.77x. The company has a Return on Equity (ROE) of 83.81% and a debt-to-equity ratio of 0.11.
Sanofi Consumer Healthcare Inc Share Price Chart — NSE/BSE Historical Performance
AI Research Briefing
Powered by Gemini · 2026-04-09
Overvalued consumer healthcare play with limited upside at current multiples.
⚡WHAT'S HAPPENING NOW (last 2-4 weeks):
No major catalysts found after live search. Last significant news was FY25 results. Sanofi Consumer Healthcare India reported a 33% jump in FY25 profit on 21% revenue growth. Q4 net profit jumped 50.11% to ₹66.50 crore, with total income increasing by 45.48% to ₹255.60 crore.
�� CORE STORY (THE REAL GAME):
Sanofi Consumer Healthcare India is a bet on the growth of the Indian consumer healthcare market, specifically in the allergy, physical wellness, and pain care segments. The market is pricing in continued growth and margin expansion, driven by strong brands and distribution network.
- Strong Q4 & FY25 results
- Dividend payout
- Overall India Pharma Growth
- Significant earnings beat
- New product launches with strong market reception
- Decrease in valuation multiples
- Rich valuation (P/E of 49.57x vs. industry P/E of 31.77x)
- FII selling (-0.3%)
- Reliance on a few key brands
FII decreased holdings by 0.3%.
Indian pharmaceutical sector is projected to grow to $130 billion by 2030, but US market headwinds could dent earnings.
Free Cash Flow 5Y: ₹None Cr
Expect moderate growth in the next 3-6 months. Valuation is a concern. Monitor for any slowdown in growth or margin compression.
Primary Thesis Risk
Valuation is stretched, leaving little margin of safety.
For educational purposes only. Not investment advice. Consult a SEBI-registered advisor before investing.
Returns & Performance
ROE
ROCE
OPM (5Y)
Div Yield
Sanofi Consumer Healthcare Inc Valuation Check
P/E Ratio
Industry P/E
Market Cap
Growth Engine
Profit Growth (Q)
Sales Growth (Q)
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Balance Sheet Health
Debt to Equity
Int. Coverage
Free Cash Flow (5Y)
Shareholding
Promoter
FII
DII
Pledged
Institutional Deep-Dive
Bull Run Research Hub
Financial Analysis of Sanofi Consumer Healthcare Inc Share Price
The pharmaceutical industry, often perceived as defensive, is currently experiencing a period of dynamic growth fueled by an aging global population and increasing healthcare spending. This analysis delves into the financial standing of Sanofi Consumer Healthcare Inc, focusing on its current market valuation and profitability. The current Sanofi Consumer Healthcare Inc share price stands at ₹4252.100098, accompanied by a Price-to-Earnings (PE) ratio of 49.57.
The PE ratio of 49.57 suggests a relatively high market expectation for future earnings growth. To gauge the reasonableness of this valuation, it's important to consider Sanofi Consumer Healthcare Inc's performance relative to its peers. While a direct comparison requires further in-depth analysis, observing competitors like Mankind Pharma Ltd gives us context.
Mankind Pharma Ltd Investigating the management quality of both companies can reveal qualitative factors potentially justifying valuation differences. A deeper dive is warranted to fully understand the sustainability of Sanofi's current valuation.A particularly striking metric is the Return on Capital Employed (ROCE) of 111.44%. This figure indicates exceptional efficiency in generating profits from invested capital. Such a high ROCE potentially strengthens Sanofi Consumer Healthcare Inc's economic moat, as it demonstrates a significant competitive advantage in deploying capital and achieving superior returns. This impressive efficiency may give Sanofi greater pricing power or the ability to invest in innovation, furthering its market position. However, it is crucial to assess the sustainability of this high ROCE; can it be maintained over the long term, or is it influenced by transient factors?
This analysis is part of a comprehensive 80-parameter fundamental audit, verified by Sweta Mishra, providing a detailed perspective on Sanofi Consumer Healthcare Inc's financial health. It is important to remember that this analysis is purely observational and does not constitute investment advice. Further due diligence is recommended before making any investment decisions.
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Sanofi Consumer Healthcare Inc Fundamental Analysis & Valuation Benchmarking
Educational evaluation of SANOFICONR across key market metrics for learning purposes.
Positive Indicators
8 factors identified
Strong Return on Equity (83.81%)
Observation: Efficient use of shareholders' capital generating superior returns.
Analysis: ROE >15% indicates strong profitability and effective management. This metric suggests the company can generate substantial returns on invested capital.
Excellent ROCE Performance (111.44%)
Observation: Superior returns on capital employed across business operations.
Analysis: ROCE >15% demonstrates efficient capital deployment and strong operational performance.
Robust Profit Growth (37.13%)
Observation: Strong year-over-year profit expansion demonstrates business momentum.
Analysis: Profit growth >20% indicates effective execution and market opportunity capture.
Strong Revenue Growth (46.28%)
Observation: Healthy sales growth indicates market demand and execution capability.
Analysis: Revenue growth >15% suggests strong market position and growth potential.
Conservative Debt Levels (D/E: 0.11)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns.
Strong Interest Coverage (153.05x)
Observation: Earnings comfortably cover interest obligations.
Analysis: Interest coverage >5x indicates low financial distress risk.
Balanced Promoter Holding (71.27%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
1 factors identified
Premium Valuation Risk (P/E: 49.57x)
Observation: High valuation multiples may limit upside potential.
Analysis: Elevated P/E ratios require strong growth execution to justify current valuations.
Sanofi Consumer Healthcare Inc Financial Statements
Comprehensive financial data for Sanofi Consumer Healthcare Inc including income statement, balance sheet and cash flow
About SANOFICONR (Sanofi Consumer Healthcare Inc)
Sanofi Consumer Healthcare Inc. is a dynamic player in the global over-the-counter (OTC) pharmaceutical landscape, dedicated to empowering individuals to proactively manage their h...ealth and well-being. With a commitment to scientific innovation and consumer-centric solutions, the company develops, manufactures, and markets a diverse portfolio of trusted brands. These brands address a broad spectrum of everyday health needs, including digestive health, pain management, allergy relief, cough, cold, and flu remedies, as well as vitamins, minerals, and supplements. Sanofi Consumer Healthcare Inc. operates with a vision to be a reliable partner in self-care, making quality healthcare accessible and convenient for consumers worldwide. Leveraging cutting-edge research and development, Sanofi Consumer Healthcare Inc. continuously strives to enhance its existing product lines and introduce innovative solutions to meet evolving consumer demands. The company's product development strategy is driven by a deep understanding of consumer needs and preferences, coupled with a commitment to rigorous scientific testing and adherence to the highest quality standards. Through strategic partnerships and acquisitions, Sanofi Consumer Healthcare Inc. expands its reach and reinforces its position as a leader in the consumer healthcare industry. The company prides itself on fostering a culture of innovation and collaboration, attracting top talent and nurturing a passion for improving people's lives. Sanofi Consumer Healthcare Inc.'s distribution network spans across multiple channels, including retail pharmacies, supermarkets, drug stores, and e-commerce platforms, ensuring convenient access to its products for consumers across diverse demographics. The company invests significantly in marketing and educational initiatives to raise awareness about its brands and empower consumers to make informed choices about their health. With a strong emphasis on ethical and responsible business practices, Sanofi Consumer Healthcare Inc. is dedicated to building long-term relationships with its customers, partners, and stakeholders, contributing to the overall well-being of communities around the globe. The company's commitment extends beyond providing effective healthcare solutions; it encompasses a dedication to sustainability and corporate social responsibility.
Company Details
Key Leadership
Corporate Events
SANOFICONR Share Price: Frequently Asked Questions
What is the current share price of Sanofi Consumer Healthcare Inc (SANOFICONR)?
As of 17 Apr 2026, 11:00 am IST, Sanofi Consumer Healthcare Inc share price is ₹4085.50. The SANOFICONR stock has a market capitalisation of ₹10.65K (Cr) on NSE/BSE.
Is SANOFICONR share price Overvalued or Undervalued?
SANOFICONR share price is currently trading at a P/E ratio of 49.57x, compared to the industry average of 31.77x. Based on this relative valuation, the Sanofi Consumer Healthcare Inc stock appears to be Overvalued against its sector peers.
What is the 52-week high and low of SANOFICONR share price?
The 52-week high of SANOFICONR share price is ₹5894.50 and the 52-week low is ₹3975.00. These values are updated daily from NSE/BSE price data.
What factors affect the Sanofi Consumer Healthcare Inc share price?
Key factors influencing SANOFICONR share price include quarterly earnings growth (Sales Growth: 46.28%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).
Is Sanofi Consumer Healthcare Inc a good stock for long-term investment?
Sanofi Consumer Healthcare Inc shows a 5-year Profit Growth of N/A% and an ROE of 83.81%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.11 before investing in SANOFICONR shares.
How does Sanofi Consumer Healthcare Inc compare with its industry peers?
Sanofi Consumer Healthcare Inc competes with major peers in the Pharmaceuticals. Investors should compare SANOFICONR share price P/E of 49.57x and ROE of 83.81% against the industry averages to determine competitive standing.
What is the P/E ratio of SANOFICONR and what does it mean?
SANOFICONR share price has a P/E ratio of 49.57x compared to the industry average of 31.77x. Investors pay ₹50 for every ₹1 of annual earnings.
How is SANOFICONR performing according to Bull Run's analysis?
SANOFICONR has a Bull Run fundamental score of 51.2/100, indicating moderate strength with some areas for improvement. This comprehensive rating is based on 15+ financial parameters.
What sector and industry does SANOFICONR belong to?
SANOFICONR operates in the Pharmaceuticals industry. This classification helps understand the competitive landscape and sector-specific trends affecting Sanofi Consumer Healthcare Inc share price.
What is Return on Equity (ROE) and why is it important for SANOFICONR?
SANOFICONR has an ROE of 83.81%, which indicates excellent management efficiency. ROE measures how efficiently Sanofi Consumer Healthcare Inc generates profits from shareholders capital.
How is SANOFICONR debt-to-equity ratio and what does it indicate?
SANOFICONR has a debt-to-equity ratio of 0.11, which indicates conservative financing with low financial risk.
What is SANOFICONR dividend yield and is it a good dividend stock?
SANOFICONR offers a dividend yield of 1.19%, meaning you receive ₹1.19 annual dividend for every ₹100 invested in Sanofi Consumer Healthcare Inc shares.
How has SANOFICONR share price grown over the past 5 years?
SANOFICONR has achieved 5-year growth rates of: Sales Growth N/A%, Profit Growth N/A%, and EPS Growth N/A%.
What is the promoter holding in SANOFICONR and why does it matter?
Promoters hold 71.27% of SANOFICONR shares, with 0.00% pledged. High promoter holding often indicates strong management confidence in Sanofi Consumer Healthcare Inc.
What is SANOFICONR market capitalisation category?
SANOFICONR has a market capitalisation of ₹10652 crores, placing it in the Mid-cap category.
How volatile is SANOFICONR stock?
SANOFICONR has a beta of N/A. A beta > 1 suggests the Sanofi Consumer Healthcare Inc stock is more volatile than the market, while a beta < 1 suggests it is less volatile.
What is SANOFICONR operating profit margin trend?
SANOFICONR has a 5-year average Operating Profit Margin (OPM) of N/A%, indicating the company's operational efficiency.
How is SANOFICONR quarterly performance?
Recent quarterly performance shows Sanofi Consumer Healthcare Inc YoY Sales Growth of 46.28% and YoY Profit Growth of 37.13%.
What is the institutional holding pattern in SANOFICONR?
SANOFICONR has FII holding of 2.94% and DII holding of 17.21%. Significant institutional holding often suggests professional confidence in the Sanofi Consumer Healthcare Inc stock.